$JNJ · Johnson & Johnson

Johnson & Johnson filed a Form 4 reporting a change in beneficial ownership for Marillyn A. Hewson, a director of the company. On September 8, 2026, Hewson acquired 180.956 Deferred Share Units under the company’s Amended and Restated Deferred Fee Plan for Directors. This acquisition represents the deferral of her cash retainer. Each Deferred Share Unit reflects the fair market value of one share of Johnson & Johnson common stock, valued at $276.31 per unit on the transaction date.

The Deferred Share Units are to be settled in cash upon the termination of Hewson’s directorship, rather than through delivery of shares. Following the reported transaction, she beneficially owns 16,049.417 Deferred Share Units. That total includes dividend equivalent rights accrued in connection with the company’s quarterly dividend on units she already held.

The filing is a routine disclosure under Section 16(a) of the Securities Exchange Act of 1934 and does not report any sale or open-market purchase of common stock.